Clinical Trials Directory

Trials / Conditions / Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

7 registered clinical trials studyying Metastatic Lung Non-Squamous Non-Small Cell Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingAurora Kinase Inhibitor LY3295668 in Combination With Osimertinib for the Treatment of Advanced or Metastatic
NCT05017025
M.D. Anderson Cancer CenterPhase 1 / Phase 2
TerminatedBintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Canc
NCT04971187
M.D. Anderson Cancer CenterPhase 2
RecruitingOsimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
NCT04181060
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTesting the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared
NCT04310007
National Cancer Institute (NCI)Phase 2
Active Not RecruitingTesting the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-s
NCT03965689
National Cancer Institute (NCI)Phase 2
CompletedNivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell L
NCT03468985
National Cancer Institute (NCI)Phase 2
CompletedOsimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic N
NCT02520778
National Cancer Institute (NCI)Phase 1